Literature DB >> 33158990

Structures and mechanism of human glycosyltransferase β1,3-N-acetylglucosaminyltransferase 2 (B3GNT2), an important player in immune homeostasis.

Yue Hao1, Amandine Créquer-Grandhomme2, Noelle Javier3, Aman Singh4, Hao Chen5, Paolo Manzanillo2, Mei-Chu Lo3, Xin Huang6.   

Abstract

β1,3-n class="Chemical">N-acetylglucon class="Chemical">saminyltransferases (B3GNTs) are Golgi-resident glycosyltransferases involved in the biosynthesis of poly-N-acetyl-lactosamine chains. They catalyze the addition of the N-acetylglucosamine to the N-acetyl-lactosamine repeat as a key step of the chain elongation process. Poly-N-acetyl-lactosamine is involved in the immune system in many ways. Particularly, its long chain has been demonstrated to suppress excessive immune responses. Among the characterized B3GNTs, B3GNT2 is the major poly-N-acetyl-lactosamine synthase, and deletion of its coding gene dramatically reduced the cell surface poly-N-acetyl-lactosamine and led to hypersensitive and hyperresponsive immunocytes. Despite the extensive functional studies, no structural information is available to understand the molecular mechanism of B3GNT2, as well as other B3GNTs. Here we present the structural and kinetic studies of the human B3GNT2. Five crystal structures of B3GNT2 have been determined in the unliganded, donor substrate-bound, acceptor substrate-bound, and product(s)-bound states at resolutions ranging from 1.85 to 2.35 Å. Kinetic study shows that the transglycosylation reaction follows a sequential mechanism. Critical residues involved in recognition of both donor and acceptor substrates as well as catalysis are identified. Mutations of these invariant residues impair B3GNT2 activity in cell assays. Structural comparison with other glycosyltransferases such as mouse Fringe reveals a novel N-terminal helical domain of B3GNTs that may stabilize the catalytic domain and distinguish among different acceptor substrates.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  enzyme mechanism; glycobiology; glycosyltransferase; poly-N-acetyl-lactosamine; structural biology; β1,3-N-acetylglucosaminyltransferase 2

Year:  2020        PMID: 33158990      PMCID: PMC7948737          DOI: 10.1074/jbc.RA120.015306

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Aberrant Protein Glycosylation in Brain Cancers, with Emphasis on Glioblastoma.

Authors:  Livia Rosa-Fernandes; Sueli Mieko Oba-Shinjo; Janaina Macedo-da-Silva; Suely Kazue Nagahashi Marie; Giuseppe Palmisano
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  How to extend your (polylactosamine) antennae.

Authors:  Matthew S Kimber
Journal:  J Biol Chem       Date:  2021-01-14       Impact factor: 5.157

3.  MOXD1 knockdown suppresses the proliferation and tumor growth of glioblastoma cells via ER stress-inducing apoptosis.

Authors:  Pengfei Shi; Jie Xu; Fanwei Xia; Yinggang Wang; Jie Ren; Ping Liang; Hongjuan Cui
Journal:  Cell Death Discov       Date:  2022-04-07

4.  Structural basis for the synthesis of the core 1 structure by C1GalT1.

Authors:  Ana Sofia Grosso; Zhang Yang; Ismael Compañón; Helena Coelho; Andrés Manuel González-Ramírez; Yoshiki Narimatsu; Henrik Clausen; Filipa Marcelo; Francisco Corzana; Ramon Hurtado-Guerrero
Journal:  Nat Commun       Date:  2022-05-03       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.